PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2026Acta Ophthalmologica0 citationsOpen Access

Risk factors for the development of subretinal fluid in the fellow eyes of patients with chronic central serous chorioretinopathy

View Full Paper
HFHelena M. A. FeenstraTCTahir CakarJBJoost Brinks

Key Points

  • The study aims to assess the risk factors for developing subretinal fluid in the unaffected fellow eyes of patients with chronic central serous chorioretinopathy.
  • Reviewed medical records of 334 cCSC patients retrospectively.
  • Evaluated multimodal imaging and optical coherence tomography for SRF development.
  • Conducted follow-up assessments over an average of 20.4 months.
  • 7% of patients with unilateral SRF developed SRF in the fellow eye.
  • 100% of those who developed SRF had retinal pigment epithelial alterations.
  • Higher rates of hyperautofluorescence observed in SRF-developing patients compared to non-developing patients.

Abstract

Abstract Purpose To assess the risk of subretinal fluid (SRF) development in the fellow eye of chronic central serous chorioretinopathy (cCSC) patients with unilateral SRF at baseline. Methods Medical records of 334 presumed cCSC patients were retrospectively reviewed. Multimodal imaging was evaluated, and the available optical coherence tomography (OCT) scans were screened for SRF development in the fellow eye during follow‐up. Results Of 213 confirmed cCSC cases, 74 (35%) had bilateral SRF at baseline. Among 102 patients with unilateral SRF that met all inclusion criteria, 7/102 (7%) developed SRF in the fellow eye over a mean follow‐up of 20.4 months. Retinal pigment epithelial (RPE) alterations in the fellow eye were present at baseline in 7/7 (100%) who developed SRF, compared to 59/95 (62%) in those who did not ( p = 0.042). Subfoveal choroidal thickness (SFCT) was higher in the SRF‐developing group (482.3 vs. 365.9 μm; p = 0.306), although not significantly. Hyperautofluorescence on fundus autofluorescence (FAF) at baseline occurred in 6/7 (86%) of the SRF‐developing group versus 25/91 (28%) who did not ( p = 0.004). The ellipsoid zone was interrupted in 5/7 (71%) of SRF‐developing patients versus 28/95 (30%) who did not develop SRF ( p = 0.005). Conclusion The risk of SRF development in the fellow eye of cCSC patients with unilateral SRF is relatively low over a follow‐up period of almost 2 years. No statistically significant risk factors were identified after correction for multiple testing; however, certain trends were observed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Feenstra et al. (2026) studied this question.

synapsesocial.com/papers/699011712ccff479cfe582abhttps://doi.org/10.1111/aos.70103
Ask AI
Helpful
Bookmark
Share
View Full Paper